KMT2A and acute myeloid leukemia: TET1 was firstly identified as a fusion partner of mixed lineage leukemia (MLL) in acute myeloid leukemia (AML) [17, 18], and the downregulation of Tet1 has been shown to promote cancer invasion and metastasis [19, 20].